Illness Understanding and Advance Care Planning in Patients with Advanced Lymphoma
Kelly M. Trevino(NewYork–Presbyterian Hospital), John P. Leonard(New York University), Peter Martin(Northwestern University), Chrystal Marte(Memorial Sloan Kettering Cancer Center), Holly G. Prigerson(Cornell University), Daniel Ouyang(Cornell University), Sarah C. Rutherford(NewYork–Presbyterian Hospital)
Cited by 13
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Health Care Costs in the Last Week of Life
|Archives of Internal Medicine|2009|900